Longitudinal Study of the Human Intestinal Microbiome

NCT00832286 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Dysbacteriosis

Interventions

DRUG: Ciprofloxacin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)